NEW YORK (GenomeWeb News) – Johnson & Johnson Pharmaceutical Research and Development has extended a licensing agreement for BioWisdom’s OmniViz visualization and data-mining software, BioWisdom said today.
BioWisdom merged with OmniViz early last year.
The OmniViz software offers visualization of text, numerical, and categorical data as well as genome sequences, chemical structures, and text files.
Financial terms of the agreement were not released.